Sonic Healthcare (STU:SAB) Current Accrued Expense: € Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SAB Sonic Healthcare Ltd STU:SAB
73 GF Score
Price €12.10
GF Value €19.74
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare Current Accrued Expense?

Sonic Healthcare STU:SAB -1.48% 73 Current Accrued Expense is € Mil as of Jun. 2026. GuruFocus rates STU:SAB with a GF Score™ of 73/100 and a GF Value™ of €19.74 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sonic Healthcare's Current Accrued Expense for the quarter that ended in Jun. 2026 was € Mil.

Sonic Healthcare's annual Current Accrued Expense declined from Jun. 2024 (€578 Mil) to Jun. 2025 (€484 Mil) and declined from Jun. 2025 (€484 Mil) to Jun. 2026 (€ Mil).

Sonic Healthcare Current Accrued Expense Related Terms

Sonic Healthcare Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Sonic Healthcare's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonic Healthcare Current Accrued Expense Chart

Sonic Healthcare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 509.60 429.65 577.62 484.30 -

Sonic Healthcare Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
STU:SAB
73GF Score
Sonic Healthcare Ltd STU:SAB
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonic Healthcare Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of € Mil mean?
Sonic Healthcare (STU:SAB) has a Current Accrued Expense of € Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Sonic Healthcare and its competitors.
Is Sonic Healthcare's Current Accrued Expense too high?
Sonic Healthcare's current Current Accrued Expense is € Mil. Overall, Sonic Healthcare has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's Current Accrued Expense compare to TMO and DHR?
Sonic Healthcare's Current Accrued Expense of € Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Sonic Healthcare and its competitors. Sonic Healthcare's current Current Accrued Expense is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (STU:SAB) is currently considered Significantly Undervalued. The stock's GF Value™ is €19.74, compared to a current price of €12.10 — trading 38.7% below its estimated fair value. The current Current Accrued Expense is € Mil. Sonic Healthcare's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Sonic Healthcare (STU:SAB), the current Current Accrued Expense is € Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonic Healthcare (STU:SAB) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of €12.10 is trading 38.7% below its estimated GF Value™ of €19.74. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for STU:SAB:

  • Current Accrued Expense: € Mil
  • GF Value™: €19.74 vs. price of €12.10 (38.7% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
73GF Score

Get the complete analysis for STU:SAB

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.10
Price
€19.74
GF Value